ABT
ABBOTT LABORATORIESPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Apr 23 to Apr 27 ▲ 2 days of insider buys: $1.1M by 2 insiders, avg $92.45
- Jun 30 ▲ 4 funds open new positions (13F)
- Aug 11 ▼ 1 insider sell $642.5K at $109.83
- Aug 25 ▼ 1 insider sell $46.2M at $115.85
- Sep 2 ▼ 1 insider sell $3.0K at $109.54
- Sep 4 to Sep 18 ▲ 2 buys: Ro Khanna, Gilbert Cisneros bought $1,001 - $15,000, last disclosed Oct 13
- Sep 17 Dividend: Abbott declares 411th consecutive quarterly dividend
- Oct 15 to Oct 27 5 court rulings: LeGrand et al v. Abbott Laboratories; Ghosh v. Abbott Laboratories, Inc. et al and 3 more
- Oct 15 ▼ Short interest jumps 27.5% to 17.39M
- Oct 21 ▲ Abbott announced its intention to spin off its global Nutrition busi…
- Oct 27 ▼ Argus Research downgrades
- Nov 5 ▼ 1 insider sell $406.0K at $116.00
Signal stack
Where each data set points today.
- InsidersBEARISH
3 insiders bought $1.3M at an average $91.65. 4 insiders sold $47.3M. Price is 18% above their cost.
- InstitutionsMIXED
Q2 2026: 61 added (4 new), 60 trimmed or exited. Largest new: Barrow Hanley Mewhinney & Strauss $324.0M, Point72 Asset Management, $140.8M.
- AnalystsBULLISH
26 of 33 rate it Buy or better. Median target $120.00 (+11%).
- Short sellersSTEADY
Short interest +9.6% to 19.06M shares. 1.9 days to cover, ≈1.1% of shares.
- TrendUPTREND
4% above its 50-day average.
- SocialQUIET
Crowd 50° (neutral) this week from 3 mentions: 0 bullish, 0 bearish. No setup is alerting.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | $5.4B |
| Capital Research Global Investors | TRIM | $3.3B |
| PRICE T ROWE ASSOCIATES INC /MD/ | ADD | $2.1B |
| JPMORGAN CHASE & CO | TRIM | $1.4B |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | $988.8M |
| FLOSSBACH VON STORCH SE | ADD | $902.9M |
| CITADEL ADVISORS LLC | DOUBLED | $780.1M |
| WELLINGTON MANAGEMENT GROUP LLP | TRIM | $753.6M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
33 analystsPrice is inside the target range. Median implies +11%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 27, 2026 | Argus Research DOWNGRADE | Hold |
| Oct 23, 2026 | Wells Fargo MAINTAIN | Overweight |
| Oct 22, 2026 | Citigroup MAINTAIN | Buy |
| Oct 22, 2026 | RBC Capital MAINTAIN | Outperform |
| Oct 22, 2026 | Wells Fargo MAINTAIN | Overweight |
| Oct 22, 2026 | JP Morgan MAINTAIN | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Moreland Mary K EXECUTIVE VICE PRESIDENT Nov 5, 2026 | SELL | $406.0K |
Conroy Kevin T Director Sep 30, 2026 | AWARD | $31.4K |
Stratton John G Director Sep 30, 2026 | AWARD | $39.2K |
Roman Michael F Director Sep 30, 2026 | AWARD | $37.7K |
Gonzalez Patricia Paola Director Sep 30, 2026 | AWARD | $32.9K |
Ahuja Nita Director Sep 30, 2026 | AWARD | $31.4K |
Conroy Kevin T Director Sep 23, 2026 | TAX W/H | $5.5M |
MCCOY JOHN A. JR. VICE PRESIDENT AND CONTROLLER Sep 2, 2026 | SELL | $3.0K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
37 filings · 1 press release · 8 bullish · 2 bearish · 3 mixed · 24 neutral- NEUTRAL 144Nov 5, 2026
Analysis based on filing metadata only; document content was unavailable. A Form 144 was filed for…
Monitor for the actual Form 4 filing to see if the sale was executed and at what price. Without the insider's identity and share count, no further action is warranted.
- NEUTRAL ANALYST-DOWNGRADEOct 27, 2026
Argus Research downgrades ABT to Hold, PT not provided
- NEUTRAL COURT-RULINGOct 27, 2026
The court entered a stipulated ESI discovery protocol in a consumer class action against Abbott…
Monitor for future substantive rulings on class certification or summary judgment in this consumer litigation. The ESI protocol is standard and does not alter the case's trajectory.
- MIXED INST-CLUSTEROct 21, 2026
A mixed institutional cluster in ABT for Q3 2026 shows four asset managers adding $277.1M in…
The buying cluster is a contrarian signal against the bearish Q3 earnings, monitor whether additional institutional buying emerges in Q4 13F filings to confirm a thesis shift, or if the sellers'…
All ABT filing & press-release reports (38)
- 144 reportNov 5, 2026
- COURT-RULING reportOct 27, 2026
- Argus Research downgrades ABT to Hold, PT not providedOct 27, 2026
- COURT-RULING reportOct 20, 2026
- INST-CLUSTER reportOct 21, 2026
- 8-K reportOct 21, 2026
- 8-K reportOct 21, 2026
- PRESS-RELEASE reportOct 21, 2026
- COURT-RULING reportOct 16, 2026
- COURT-RULING reportOct 15, 2026
- Barclays Initiates ABT at Overweight, PT $120 (+19.9%)Oct 7, 2026
- Rothschild& Co upgrades ABT to Buy, PT $127 (+31.4%)Oct 2, 2026
- Rothschild & Co upgrades ABT to Buy, PT $127 (+31.3%)Oct 2, 2026
- COURT-RULING reportSep 30, 2026
- COURT-RULING reportSep 29, 2026
- PRESS-RELEASE reportSep 17, 2026
- COURT-RULING reportSep 14, 2026
- COURT-RULING reportSep 15, 2026
- COURT-RULING reportAug 11, 2026
- COURT-RULING reportAug 11, 2026
- COURT-RULING reportJul 31, 2026
- INST-CLUSTER reportJul 31, 2026
- COURT-RULING reportJul 24, 2026
- COURT-RULING reportJul 14, 2026
- 8-K reportJul 16, 2026
- COURT-RULING reportJul 7, 2026
- COURT-RULING reportMar 26, 2026
- Baird initiates ABT at Outperform, PT $121 (+33%)Jul 1, 2026
- COURT-RULING reportApr 22, 2026
- COURT-RULING reportMay 28, 2026
- CLUSTER reportApr 23, 2026
- 8-K reportApr 27, 2026
- 8-K reportApr 17, 2026
- 8-K reportApr 16, 2026
- COURT-RULING reportMar 30, 2026
- 8-K reportMar 23, 2026
- DEFA14A reportMar 13, 2026
- CLUSTER reportMar 2, 2026